Regulation of inflammation by interleukin-4: a review of “alternatives”

IG Luzina, AD Keegan, NM Heller… - Journal of leukocyte …, 2012 - academic.oup.com
Review on three IL-4-related branch points for immune regulation: alternative splicing of IL-
4, differential receptor engagement, and differential regulation of macrophage activation by …

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes

E Schutyser, A Richmond… - Journal of leukocyte …, 2005 - academic.oup.com
Abstract CC chemokine ligand 18 (CCL18) was originally discovered as pulmonary and
activation-regulated chemokine (PARC), dendritic cell (DC)-chemokine 1 (DC-CK1) …

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18

A Prasse, DV Pechkovsky, GB Toews… - American journal of …, 2006 - atsjournals.org
Rationale: Recently, models of macrophage activation have been revised. Macrophages
stimulated with Th2 cytokines have been classified as alternatively activated. Objectives …

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

RG Boot, M Verhoek, M De Fost, CEM Hollak, M Maas… - Blood, 2004 - ashpublications.org
Gaucher disease is characterized by storage of glucosylceramide in lysosomes of tissue
macrophages as the result of an autosomal recessively inherited deficiency in …

Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts

SP Atamas, IG Luzina, J Choi… - American journal of …, 2003 - atsjournals.org
Levels of pulmonary and activation-regulated chemokine (PARC) mRNA and protein are
increased in the lungs of patients with pulmonary fibrosis. The purpose of this study was to …

Serum pulmonary and activation‐regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis

M Kodera, M Hasegawa, K Komura… - Arthritis & …, 2005 - Wiley Online Library
Objective To clarify the clinical significance of serum levels of pulmonary and activation‐
regulated chemokine (PARC) in the diagnosis and monitoring of pulmonary fibrosis (PF) in …

[HTML][HTML] CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases

M Cai, F Bonella, X He, SU Sixt, R Sarria, J Guzman… - Respiratory …, 2013 - Elsevier
Background CCL18 is a CC chemokine produced mainly by antigen-presenting cells, and is
chemotactic predominantly for T-lymphocytes. CCL18 can stimulate pulmonary fibroblasts …

Sarcoidosis-immunopathogenetic concepts

G Zissel, A Prasse… - Seminars in respiratory …, 2007 - thieme-connect.com
Sarcoidosis is a chronic granulomatous disorder characterized by an accumulation of
activated lymphocytes, predominantly T helper cells, expressing the Th1 phenotype and …

Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas

E Bargagli, A Mazzi, P Rottoli - Clinics in chest medicine, 2008 - Elsevier
Sarcoidosis is characterized by intense inflammation at the different sites of localization.
Many different mediators, such as cytokines, chemokines, and other proteins with various …

Cytokines in chronic respiratory diseases

SP Atamas, SP Chapoval, AD Keegan - F1000 biology reports, 2013 - pmc.ncbi.nlm.nih.gov
Cytokines are small, secreted proteins that control immune responses. Within the lung, they
can control host responses to injuries or infection, resulting in clearance of the insult, repair …